Australian Clinical Labs (ASX:ACL) Ending Cash Position : A$24.9 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Ending Cash Position?

Australian Clinical Labs's Ending Cash Position for the quarter that ended in Dec. 2023 was A$24.9 Mil.

Australian Clinical Labs's quarterly Ending Cash Position increased from Dec. 2022 (A$16.1 Mil) to Jun. 2023 (A$20.0 Mil) and increased from Jun. 2023 (A$20.0 Mil) to Dec. 2023 (A$24.9 Mil).

Australian Clinical Labs's annual Ending Cash Position declined from Jun. 2021 (A$35.2 Mil) to Jun. 2022 (A$26.4 Mil) and declined from Jun. 2022 (A$26.4 Mil) to Jun. 2023 (A$20.0 Mil).

Australian Clinical Labs Ending Cash Position Historical Data

The historical data trend for Australian Clinical Labs's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Ending Cash Position Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Ending Cash Position

35.23

26.37

19.96

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial			47.33	26.37	16.13	19.96	24.94

Australian Clinical Labs Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Australian Clinical Labs's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	26.372	+	-6.417
	=	20.0

Australian Clinical Labs's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	19.955	+	4.983
	=	24.9

Australian Clinical Labs Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines